Surface Oncology, Inc. 4 SEC Filings

Filed On	Filing
08 Sep 2023	Form 4: Sigal Charles Elliott, Director Returned 45,453 shares to the issuer · Disposed of 113,636 Stock Option (Right to Buy) (Disposition to Issuer)
08 Sep 2023	Form 4: Adams Chandra, Deputy GC Returned 23,884 shares to the issuer · Disposed of 100,000 Stock Option (Right to Buy) (Disposition to Issuer)
08 Sep 2023	Form 4: Rath Henry C., Chief Business Officer Returned 44,971 shares to the issuer · Disposed of 150,000 Stock Option (Right to Buy) (Disposition to Issuer)
08 Sep 2023	Form 4: Palombella Vito J., Chief Scientific Officer Returned 87,212 shares to the issuer · Disposed of 150,000 Stock Option (Right to Buy) (Disposition to Issuer)
08 Sep 2023	Form 4: Goater Jeff, Director Returned 129,222 shares to the issuer
08 Sep 2023	Form 4: Fees Jessica, Chief Financial Officer Returned 101,915 shares to the issuer · Disposed of 150,000 Stock Option (Right to Buy) (Disposition to Issuer)
08 Sep 2023	Form 4: Ross Robert W., Director Returned 83,193 shares to the issuer · Disposed of 400,000 Stock Option (Right to Buy) (Disposition to Issuer)
08 Sep 2023	Form 4: Grayzel David S., Director Returned 2,945,453 shares to the issuer
08 Sep 2023	Form 4: Oneill Alison, Chief Medical Officer Returned 56,686 shares to the issuer · Disposed of 150,000 Stock Option (Right to Buy) (Disposition to Issuer)
11 Aug 2023	Form 4: Adams Chandra, Deputy GC Sold 3,901 shares ($3.67K)
11 Aug 2023	Form 4: Fees Jessica, Chief Financial Officer Sold 9,434 shares ($8.87K)
11 Aug 2023	Form 4: Oneill Alison, Chief Medical Officer Sold 7,042 shares ($6.62K)
11 Aug 2023	Form 4: Ross Robert W., Chief Executive Officer Sold 16,713 shares ($15.7K)
03 Mar 2023	Form 4: Rath Henry C., Chief Business Officer Granted 150,000 Stock Option (Right to Buy)
03 Mar 2023	Form 4: Ross Robert W., Chief Executive Officer Granted 400,000 Stock Option (Right to Buy)
03 Mar 2023	Form 4: Adams Chandra, Deputy GC Granted 100,000 Stock Option (Right to Buy)
03 Mar 2023	Form 4: Oneill Alison, Chief Medical Officer Granted 150,000 Stock Option (Right to Buy)
03 Mar 2023	Form 4: Fees Jessica, Chief Financial Officer Granted 150,000 Stock Option (Right to Buy)
03 Mar 2023	Form 4: Palombella Vito J., Chief Scientific Officer Granted 150,000 Stock Option (Right to Buy)
03 Nov 2022	Form 4: Adams Chandra, Deputy GC Granted 30,000 Stock Option (Right to Buy)

Comments